Human CD8+ T Cells for Research

Human CD8+ T Cells for Research

Source human CD8+ T cells and CD8 T cell samples for immunology, oncology, and cell therapy research. Healthy and disease-state donor options are available.

Human CD8+ T cells are purified from peripheral blood of IRB-consented donors under IRB-approved protocols. These isolated CD8+ T cell samples support cytotoxic T cell biology, cancer immunotherapy, autoimmune disease research, and other human T cell research applications. Available cryopreserved, these CD8+ T cells deliver high viability and consistent performance for in vitro and in vivo studies.

Product Features

  • Human CD8+ T cells for Research Use Only (RUO)
  • CD8 positive T cells
  • Isolated human CD8+ T cell samples from healthy, clinically screened donors
  • High-purity isolated CD8+ T cells with ≥90% CD8+ viability
  • Cryopreserved in CryoStor® CS10 media
  • Processed within 24 hours of collection
  • IRB-approved protocols with electronic informed consent

Donor Metadata

  • Comprehensive donor screening and verified health status
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Self-reported medication, allergy, and infectious disease history

Applications

  • Cytotoxic T cell activation and degranulation assays
  • Antigen-specific killing and target cell cytotoxicity studies
  • Cancer immunotherapy and CAR-T research
  • Autoimmune and inflammatory disease research
  • Viral immunity and HIV studies
  • Single-cell sequencing and transcriptomic profiling

Compliance and Quality Assurance

  • IRB-approved collections and standardized procedures
  • 21 CFR Part 11–compliant e-consent system
  • HIPAA-compliant data management

Buy Human CD8+ T Cells for Research

Purchase human CD8+ T cell samples for research, including isolated CD8+ T cells from healthy or disease-state donors, with flexible aliquots and documentation support.

Ordering & Customization

Purchase human CD8+ T cells in standard or custom aliquots. For international orders or regulatory compliance documentation, please contact learnmore@sanguinebio.com. If you need to buy CD8+ T cells for research with specific donor criteria, Sanguine can support custom sourcing and documentation support.

Frequently Asked Questions

Showing 1–12 of 20 results

Are samples IRB approved?

1 Answer

YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.

YES – with the exception of GMP leukopaks, all our products are research use only (RUO).

Our complete catalog can be found here: https://sanguinebio.com/products/

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

YES – Unique donors can be specified and guaranteed based on your requirements.

For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/

YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

1 2
×

Ask a Question

Need a custom CD8+ T Cells cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information